Immuno-Oncology Therapeutic Manufacturers, Suppliers & Companies
-
Manufacturerbased in Bryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
IBIO - Model 101 - Immuno Oncology Therapeutics
Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as ...
CONTACT SUPPLIER -
Software vendorbased in Hackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
Autologous Tumor Infiltrating Lymphocyte (TIL) Platform
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for ...
-
Manufacturerbased in Lyon, FRANCE
Mablink Bioscience is a French-based biotechnology company specialized in the development of an emerging class of cancer drugs, called antibody-drug conjugates (ADCs). Mablink leverages its patented hydrophilic technology PSARlink™ that enables the ...
Mablink - Antibody–Drug Conjugates (ADCs) Technology
Antibody–drug conjugates (ADCs) are a unique class of targeted immuno-oncology therapeutics that combine the tumor-targeting selectivity, stability, and favorable pharmacokinetic profile of ...
CONTACT SUPPLIER -
Manufacturerbased in Tarrytown, NEW YORK (USA)
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently ...
VelociT - Unique Mouse Technology
elociT™ is our unique mouse technology for producing fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens. Regeneron uses this technology as part of its efforts to discover and develop novel ...
CONTACT SUPPLIER -
Manufacturerbased in San Francisco, CALIFORNIA (USA)
Prellis Biologics, Inc. utilizes its proprietary, high-resolution bioprinting technology to recreate and engineer human tissues in vitro. A key application is Prellis’ Externalized Immune System, EXIS, which through the creation of lymph node ...
EXIS Platform - Externalized Immune System
EXIS Human Immune Response: Prellis utilizes its proprietary holographic printing technology to engineer 3D printed lymph node organoids (LNOs) that recreates the human immunobiology in vitro allowing direct access to a fully functional human immune ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
Pascal Biosciences Inc. (TSXV:PAS, FSE:6PB.F) is a biopharmaceutical company founded in 2013 to advance technology licensed from the University of British Columbia. We create additional value with programs licensed from other organizations and with ...
Pascal - Model PAS-393 - Cannabinoid-Based Therapeutic for Restoring Immune Recognition Cancer
cells and cancer cells has tremendous potential in the field of ...
CONTACT SUPPLIER -
Manufacturerbased in Durham, NORTH CAROLINA (USA)
Cancer is the second leading cause of death in the U.S. and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the most effective ...
Drug Development Services
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, ...
CONTACT SUPPLIER -
Technologybased in Vancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
-
Manufacturerbased in Niel, BELGIUM
eTheRNA has developed a proprietary and integrated set of platform technologies that are overcoming the challenges facing the development of next generation mRNA therapeutics. Our platform includes mRNA construct design and optimization, proprietary ...
eTheRNA - Model ITu-LNP - LNP Platforms
Therapeutic area: immuno-oncology; Intra-tumoral (IT) ...
CONTACT SUPPLIER -
Manufacturerbased in Buffalo, NEW YORK (USA)
Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor ...
-
Manufacturerbased in New York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
-
Manufacturerbased in Nantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
OSE - Model CLEC-1 - Antagonist Monoclonal Antibodies
OSE’s R&D team and its academic partners have characterized the myeloid checkpoint CLEC-1 (a C-type lectin receptor) as a new therapeutic target in immuno-oncology and identified ...
CONTACT SUPPLIER -
Technologybased in Dijon, FRANCE
Oncodesign is a biopharmaceutical company that offers you powerful technologies and tools to guide you through the development of your drug, from medicinal chemistry to drug candidate. Our therapeutic areas are expanding. In addition to oncology, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you